Policy | April 10, 2026
NITI Aayog releases reports to improve ease of doing R&D in India
The reports will now be shared with relevant ministries and departments as a guidance framework
The reports will now be shared with relevant ministries and departments as a guidance framework
A major highlight of the event was the launch of several publications and digital initiatives, including a certification course on the Ayush Grid portal
New digital health companion uses friendly, jargon-free communication to help users better understand reports
CSR-led ‘Too Shy to Ask’ program expands across 1,000+ villages, with Panchayat-backed adolescent leadership driving behavioural change
Drugmaker taps 1 million retail touchpoints, quick commerce and modern trade to expand ingredient-led skincare franchise
Final approval for progesterone vaginal inserts expands Glenmark’s women’s healthcare portfolio in the US, targeting a market of over $59 million
In just the last few days, companies including Lupin, Biocon, Alembic Pharmaceuticals and Aurobindo Pharma have announced approvals for 5 mg and 10 mg tablets, all bioequivalent to Farxiga
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
Both ordinary resolutions sail through with over 99.6% votes in favour, strengthening leadership continuity at the drugmaker
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
